Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England : Results of a Modified Prescription-Event Monitoring Study.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Regulatory T-cell vaccination independent of auto-antigen.
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Identification of a microglia phenotype supportive of remyelination.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Quantitative metabolic profiling of lipid mediators.
Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy.
Life on hold: the experience of living with neuromyelitis optica.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
White matter disease: Hyaluronidase PH-20 digestion products inhibit remyelination in demyelinating lesions.
The effect of delayed percutaneous nephrolithotomy on the risk of bacteremia and sepsis in patients with neuromuscular disorders.
Early presentation of neuromyelitis optica.
Diagnostic uncertainty of tumefactive cystic demyelinating lesions.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis.
Incidence of Radiologically Isolated Syndrome: A Population-Based Study.
Microsurgical Pontine Descending Tractotomy in Cases of Intractable Trigeminal Neuralgia.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Pages
« first
‹ previous
…
365
366
367
368
369
370
371
372
373
…
next ›
last »